Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus : a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group
A double-blind study was conducted to evaluate the efficacy, safety and usefulness of cimetropium bromide (DA3177) in the patients with pain caused by upper urinary calculus at a daily dose of 75 mg t.i.d. (Group D, 97 patients) in comparison with scopolamine butylbromide at a daily dose of 60 mg t....
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 43(1997), 7 vom: 06. Juli, Seite 525-38 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1997
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Clinical Trial Clinical Trial, Phase III Comparative Study English Abstract Journal Article Multicenter Study Randomized Controlled Trial Parasympatholytics Scopolamine Derivatives cimetropium plus... |